(Visited 205 times, 1 visits today)
DelveInsight Blog
Trending:
Happy Republic Day !!!
Jan 26, 2017 | Reading Time: < 1 minute
DelveInsight launches Indication Active Ph...
Jul 07, 2015
DelveInsight expertise over 400+ Indication Active Pharmaceutical Ingredient (API) Reports DelveInsight, leading Mark...
DelveInsight’s Marketed and Pipeline Repor...
Aug 01, 2014
“If a market is growing enormously, you need to understand what’s nourishing it” DelveInsight has launched its Report...
Medical tourism in India
Mar 20, 2017
India is well known for its monuments and scenic beauty across the globe, but what if I say that Medical…
Sign Up and Stay Informed
Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
Editor's Pick
Angelman syndrome Pipeline: Unmet needs call for a robust pipeline
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...
Neurological disorders are one of the major causes of death and disability across the g...
Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...
As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...
Unity’s advanced vascular eye disease trial; Rallybio raises $100 M; Sa...
UNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Ad...
RECENT ARTICLES
